MA40990A - Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle - Google Patents
Formulations de matrice pharmaceutique comprenant du fumarate de diméthyleInfo
- Publication number
- MA40990A MA40990A MA040990A MA40990A MA40990A MA 40990 A MA40990 A MA 40990A MA 040990 A MA040990 A MA 040990A MA 40990 A MA40990 A MA 40990A MA 40990 A MA40990 A MA 40990A
- Authority
- MA
- Morocco
- Prior art keywords
- dimethyl fumarate
- formulations including
- matrix formulations
- including dimethyl
- pharmaceutical matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462081907P | 2014-11-19 | 2014-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40990A true MA40990A (fr) | 2017-09-26 |
Family
ID=54838418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA040990A MA40990A (fr) | 2014-11-19 | 2015-11-18 | Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle |
Country Status (13)
Country | Link |
---|---|
US (2) | US20190083404A1 (fr) |
EP (1) | EP3220897A1 (fr) |
JP (2) | JP6901393B2 (fr) |
KR (1) | KR20170086053A (fr) |
CN (2) | CN107205942A (fr) |
AU (2) | AU2015349891B2 (fr) |
CA (1) | CA2967645A1 (fr) |
EA (1) | EA201791089A1 (fr) |
HK (1) | HK1244215A1 (fr) |
IL (1) | IL252105A0 (fr) |
MA (1) | MA40990A (fr) |
MX (1) | MX2017006561A (fr) |
WO (1) | WO2016081671A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016273068A1 (en) | 2015-06-01 | 2017-12-21 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical compositions of dimethyl fumarate |
WO2023036702A1 (fr) | 2021-09-09 | 2023-03-16 | It Pharmagus Limited | Procédé destiné à la fabrication d'un corps solide sous forme galénique orale d'un produit pharmaceutique ou d'un complément alimentaire |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0013825A (pt) * | 1999-08-31 | 2002-07-23 | Gruenenthal Chemie | Formas de apresentação de tramadol |
EP1886665A1 (fr) * | 2006-08-01 | 2008-02-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Système thérapeutique gastro-retentif |
EP3295936A1 (fr) * | 2009-01-09 | 2018-03-21 | Forward Pharma A/S | Formulation pharmaceutique comprenant un ou plusieurs esters d'acide fumarique dans une matrice d'érosion |
EP2424357A4 (fr) * | 2009-04-29 | 2012-10-10 | Biogen Idec Inc | Traitement de la neurodégénérescence et de la neuroinflammation |
AU2012222074A1 (en) * | 2011-02-25 | 2013-09-12 | National Institutes Of Health | Chalcone derivatives as Nrf2 activators |
US20130158077A1 (en) * | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
US20130216615A1 (en) * | 2012-02-07 | 2013-08-22 | David Goldman | Pharmaceutical Compositions Containing Dimethyl Fumarate |
WO2014031897A1 (fr) * | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Formes pharmaceutiques orales possédant une charge élevée de (n,n-diéthylcarbamoyl)méthyl méthyl(2e)but-2-ène-l,4-dioate |
ES2733961T3 (es) * | 2012-12-21 | 2019-12-03 | Biogen Ma Inc | Derivados de fumarato sustituidos con deuterio |
CN105369562B (zh) * | 2014-08-28 | 2019-12-20 | 青岛海尔洗衣机有限公司 | 一种带有防衣物褪色提醒功能的洗衣机 |
-
2015
- 2015-11-18 MA MA040990A patent/MA40990A/fr unknown
- 2015-11-19 JP JP2017527358A patent/JP6901393B2/ja active Active
- 2015-11-19 CN CN201580073819.3A patent/CN107205942A/zh active Pending
- 2015-11-19 EA EA201791089A patent/EA201791089A1/ru unknown
- 2015-11-19 WO PCT/US2015/061448 patent/WO2016081671A1/fr active Application Filing
- 2015-11-19 MX MX2017006561A patent/MX2017006561A/es unknown
- 2015-11-19 EP EP15807731.3A patent/EP3220897A1/fr not_active Withdrawn
- 2015-11-19 CA CA2967645A patent/CA2967645A1/fr not_active Abandoned
- 2015-11-19 AU AU2015349891A patent/AU2015349891B2/en not_active Ceased
- 2015-11-19 US US15/527,539 patent/US20190083404A1/en not_active Abandoned
- 2015-11-19 CN CN202110530137.8A patent/CN113262205A/zh active Pending
- 2015-11-19 KR KR1020177014588A patent/KR20170086053A/ko active IP Right Grant
-
2017
- 2017-05-04 IL IL252105A patent/IL252105A0/en unknown
-
2018
- 2018-03-18 HK HK18103740.7A patent/HK1244215A1/zh unknown
-
2019
- 2019-02-14 US US16/275,739 patent/US20190175510A1/en not_active Abandoned
-
2021
- 2021-06-16 JP JP2021100203A patent/JP2021152046A/ja active Pending
- 2021-06-23 AU AU2021204247A patent/AU2021204247A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA201791089A1 (ru) | 2017-11-30 |
EP3220897A1 (fr) | 2017-09-27 |
CA2967645A1 (fr) | 2016-05-26 |
AU2015349891A1 (en) | 2017-05-25 |
JP2021152046A (ja) | 2021-09-30 |
HK1244215A1 (zh) | 2018-08-03 |
AU2015349891B2 (en) | 2021-04-01 |
WO2016081671A1 (fr) | 2016-05-26 |
CN107205942A (zh) | 2017-09-26 |
US20190175510A1 (en) | 2019-06-13 |
AU2021204247A1 (en) | 2021-07-22 |
CN113262205A (zh) | 2021-08-17 |
KR20170086053A (ko) | 2017-07-25 |
US20190083404A1 (en) | 2019-03-21 |
WO2016081671A8 (fr) | 2016-07-21 |
JP2017534667A (ja) | 2017-11-24 |
IL252105A0 (en) | 2017-07-31 |
MX2017006561A (es) | 2018-02-21 |
JP6901393B2 (ja) | 2021-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL246978A0 (en) | New paracetamol formulations | |
BR112018009951A2 (pt) | fármaco oftálmico | |
DK3722274T3 (da) | 2-perfluorbutylpentan til oftalmisk indgivelse | |
MA42844A (fr) | Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1 | |
DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
DK3171921T3 (da) | Lægemiddelafgivelsesindretning | |
MA50541A (fr) | Formulations pharmaceutiques | |
MA42303A (fr) | Formulations pharmaceutiques | |
DK3634377T3 (da) | Farmaceutisk formulering | |
MA46867A (fr) | Formulations pharmaceutiques | |
DK3348260T3 (da) | Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse | |
DK3199161T3 (da) | Farmaceutisk præparat | |
MA40982A (fr) | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle | |
MA43705A (fr) | Formulation pharmaceutique | |
DE102015120393A8 (de) | Lendenstützvorrichtung | |
MA47516A (fr) | Composition pharmaceutique | |
MA49822A (fr) | Combinaison pharmaceutique comprenant du ponesimod | |
MA44079A (fr) | Compositions pharmaceutiques comprenant un dérivé de phénylaminopyrimidine | |
DK2992967T3 (da) | Medikamentdispenser | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
MA45126A (fr) | Formulation pharmaceutique antifongique | |
EP3383371C0 (fr) | Formulation pharmaceutique | |
MA40990A (fr) | Formulations de matrice pharmaceutique comprenant du fumarate de diméthyle | |
DK3215118T3 (da) | Lægemiddelanordningsenhed indeholdende quinagolid |